Anaesthetic considerations for patients with neurosurgical implants

Whitney, P-S; Sturgess, Jane

doi:10.1093/bjaed/mkv049

Cited by 11 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prior to RFA or any procedure that might interfere with an ITP, the provider should determine age of the device, the last time the pump was interrogated, current pump medication(s), and when the patient is due for refill or pump change. 33 Most pumps last 5–7 years and require a refill every 1–6 months, with this interval contingent on drug delivery rate and reservoir volume. 34 When known, it is recommended to review the manufacturer’s guidelines for the specific device used.…”

Section: Resultsmentioning

confidence: 99%

The American Society of Pain and Neuroscience (ASPN) Guidelines for Radiofrequency Ablative Procedures in Patients with Implanted Devices

Sowder,

Sayed,

Concannon

et al. 2023

JPR

View full text Add to dashboard Cite

Radiofrequency ablation (RFA) is a treatment modality used in interventional pain management to treat several conditions including chronic neck or back pain, sacroiliac joint pain, major joint pain, and pain from sites that can be isolated to a sensory nerve amenable to RFA. The goals of such procedures are to reduce pain, improve function, delay need for surgical intervention, and reduce pain medication consumption. As applications for RFA expand through novel techniques and nerve targets, there is concern with how RFA may impact patients with implanted medical devices. Specifically, the electrical currents used in RFA produce electromagnetic interference, which can result in unintentional energy transfer to implanted devices. This may also interfere with device function or cause damage to the device itself. As the number of patients with implanted devices increases, it is imperative to establish guidelines for the management of implanted devices during RFA procedures. This review aims to establish guidelines to assist physicians in the preoperative, intraoperative, and postoperative management of implanted devices in patients undergoing procedures using radiofrequency energy. Here, we provide physicians with background knowledge and a summary of current evidence to allow safe utilization of RFA treatment in patients with implanted devices such as cardiac implantable electronic devices, spinal cord stimulators, intrathecal pumps, and deep brain stimulators. While these guidelines are intended to be comprehensive, each patient should be assessed on an individual basis to optimize outcomes.

show abstract

Section: Resultsmentioning

confidence: 99%

The American Society of Pain and Neuroscience (ASPN) Guidelines for Radiofrequency Ablative Procedures in Patients with Implanted Devices

Sowder,

Sayed,

Concannon

et al. 2023

JPR

View full text Add to dashboard Cite

show abstract

“…Prior to any procedure that might interfere with an IDDS, the care team should determine the age of the device, the last time the pump was evaluated, current pump medication and dose including whether it is flex dosing or on demand dosing, and when the patient is due for a refill or a pump change . The majority of pumps are designed to last 5–7 years, and are refilled approximately every 1–6 months .…”

Section: Resultsmentioning

confidence: 99%

Perioperative and Periprocedural Care of Patients With Intrathecal Pump Therapy

Nadherny

Anderson

Abd‐Elsayed

2019

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

“… Asepsis, full barrier protection and antibiotic prophylaxis to avoid CNS infections [2].  Postoperatively maintain adequate hydration and make patient aware of signs and symptoms of raised ICP with instructions to report immediately [1].…”

Section: Discussionmentioning

confidence: 99%

A case of grade 3 haemmorhoids with non-obstructive hydrocephalus having ventriculo-peritoneal shunt in situ posted for haemmorhoidectomy under Saddle anaesthesia

Vijay Patil,

Anupriya Chaturvedi,

Akshay Maroti Junghare

et al. 2023

Int. J. Sci. Res. Arch.

View full text Add to dashboard Cite

Now a days ventriculo-peritoneal (VP) shunts are one of the most commonly performed neurosurgical procedures. These patients can present for various surgeries in later period of life and anaesthetic management may become difficult and complicated in them. Subarachnoid block can be considered as suitable options in patients with no signs of raised intracranial tension having VP-shunt in situ posted for short surgical procedure like hemorrhoidectomy with due attention towards adequate hydration, strict asepsis and antimicrobial prophylaxis.

show abstract

Anaesthetic considerations for patients with neurosurgical implants

Cited by 11 publications

References 17 publications

The American Society of Pain and Neuroscience (ASPN) Guidelines for Radiofrequency Ablative Procedures in Patients with Implanted Devices

The American Society of Pain and Neuroscience (ASPN) Guidelines for Radiofrequency Ablative Procedures in Patients with Implanted Devices

Perioperative and Periprocedural Care of Patients With Intrathecal Pump Therapy

A case of grade 3 haemmorhoids with non-obstructive hydrocephalus having ventriculo-peritoneal shunt in situ posted for haemmorhoidectomy under Saddle anaesthesia

Contact Info

Product

Resources

About